265 related articles for article (PubMed ID: 209958)
1. Corticosteroids: clinical pharmacology and therapeutic use.
Swartz SL; Dluhy RG
Drugs; 1978 Sep; 16(3):238-55. PubMed ID: 209958
[TBL] [Abstract][Full Text] [Related]
2. CRH test prior to discontinuation of long-term low-dose glucocorticoid therapy.
Gellner R; Stange M; Schiemann U; Domschke W; Hengst K
Exp Clin Endocrinol Diabetes; 1999; 107(8):561-7. PubMed ID: 10612488
[TBL] [Abstract][Full Text] [Related]
3. Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.
Brogden RN; Pinder RM; Sawyer PR; Speight TM; Avery GS
Drugs; 1975; 10(3):166-210. PubMed ID: 172309
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoids in clinical practice.
Holland EG; Taylor AT
J Fam Pract; 1991 May; 32(5):512-9. PubMed ID: 2022941
[TBL] [Abstract][Full Text] [Related]
5. Adrenal axis function after high-dose steroid therapy for childhood acute lymphoblastic leukemia.
Einaudi S; Bertorello N; Masera N; Farinasso L; Barisone E; Rizzari C; Corrias A; Villa A; Riva F; Saracco P; Pastore G
Pediatr Blood Cancer; 2008 Mar; 50(3):537-41. PubMed ID: 17828747
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacology of glucocorticoids and ENT pathology].
Devillier P
Presse Med; 2001 Dec 22-29; 30(39-40 Pt 2):59-69. PubMed ID: 11819915
[TBL] [Abstract][Full Text] [Related]
7. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
[TBL] [Abstract][Full Text] [Related]
9. [How to plan glucocorticoid withdrawal: diagnostic and therapeutic strategies].
Vollenweider P; Waeber G
Praxis (Bern 1994); 2003 Oct; 92(40):1675-82. PubMed ID: 14579472
[TBL] [Abstract][Full Text] [Related]
10. Corticosteroid therapy in asthma.
Dunlap NE; Fulmer JD
Clin Chest Med; 1984 Dec; 5(4):669-83. PubMed ID: 6151441
[TBL] [Abstract][Full Text] [Related]
11. A search for variables predicting cortisol response to low-dose corticotropin stimulation following supraphysiological doses of glucocorticoids.
Wildi-Runge S; Deladoëy J; Bélanger C; Deal CL; Van Vliet G; Alos N; Huot C
J Pediatr; 2013 Aug; 163(2):484-8. PubMed ID: 23414662
[TBL] [Abstract][Full Text] [Related]
12. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation.
Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G
J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625
[TBL] [Abstract][Full Text] [Related]
13. The antiglucocorticoid and antiprogestin steroid RU 486 suppresses the adrenocorticotropin response to ovine corticotropin releasing hormone in man.
Laue L; Chrousos GP; Loriaux DL; Barnes K; Munson P; Nieman L; Schaison G
J Clin Endocrinol Metab; 1988 Feb; 66(2):290-3. PubMed ID: 2828406
[TBL] [Abstract][Full Text] [Related]
14. Steroid withdrawal syndrome after successful treatment of Cushing's syndrome: a reminder.
Bhattacharyya A; Kaushal K; Tymms DJ; Davis JR
Eur J Endocrinol; 2005 Aug; 153(2):207-10. PubMed ID: 16061825
[TBL] [Abstract][Full Text] [Related]
15. Chronobiology and asthma. III. Timing corticotherapy to biological rhythms to optimize treatment goals.
Reinberg A; Smolensky MH; D'Alonzo GE; McGovern JP
J Asthma; 1988; 25(4):219-48. PubMed ID: 2846506
[TBL] [Abstract][Full Text] [Related]
16. Corticoid therapy: how?
Rubens R
Bull Soc Belge Ophtalmol; 1990; 236():45-55. PubMed ID: 1965530
[TBL] [Abstract][Full Text] [Related]
17. [Glucocorticoids in pediatrics].
Radmanović SZ
Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():58-62. PubMed ID: 18193804
[TBL] [Abstract][Full Text] [Related]
18. The influence of Graves' orbitopathy treatment with intravenous glucocorticoids on adrenal function.
Ambroziak U; Bluszcz G; Bednarczuk T; Miśkiewicz P
Endokrynol Pol; 2017; 68(4):430-433. PubMed ID: 28604944
[TBL] [Abstract][Full Text] [Related]
19. Minimizing complications from systemic glucocorticosteroid use.
Nesbitt LT
Dermatol Clin; 1995 Oct; 13(4):925-39. PubMed ID: 8785896
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic issues in oral glucocorticoid use.
Bello CE; Garrett SD
Lippincotts Prim Care Pract; 1999; 3(3):333-41; quiz 342-4. PubMed ID: 10711134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
